Trials / Completed
CompletedNCT06994286
The Purpose of This Study is to Investigate the Safety, Tolerability and Pharmacokinetics of MT-7117 in Healthy Subjects.
A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Pharmacokinetics, Safety, Tolerability and Pharmacodynamics of Single and Multiple Doses of MT-7117 in Chinese Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Tanabe Pharma Corporation · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to investigate the safety, tolerability and pharmacokinetics of MT-7117 in Chinese healthy subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MT-7117 | Oral |
| DRUG | Placebo | Oral |
Timeline
- Start date
- 2025-06-24
- Primary completion
- 2025-07-21
- Completion
- 2025-08-04
- First posted
- 2025-05-29
- Last updated
- 2026-04-03
Locations
1 site across 1 country: China
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06994286. Inclusion in this directory is not an endorsement.